The Lessons Learned sessions, which kicked off in 2014 promoted by CataloniaBio & HealthTech, are a knowledge forum for professionals in the biomedicine and health sector to share experiences in various strategic areas to boost the competitiveness of companies.

Experts are invited to share their lessons learned (good and bad!), reflections and view of the future. Participants are invited to participate actively in the sessions. 

The Lessons Learned sessions are also a great opportunity for networking.

Between 2014 and 2020, 25 sessions were held with 135 speakers and over 900 professionals from various areas of business (R&D, innovation, regulatory affairs, market access, finance, communication, etc.).

For members and non-members

Previous editions

• Cracking the medtech market access code
• Public procurement of innovation: could we do it better?
• Cybersecurity in health
• Learning to plan the journey: from drug discovery to first-in-humans
• Medical device audits, a long-distance race
• Supplier management in the sustainability strategy
• From 3D printing in health to bioprinting
• Experiences on the trading floor
• Improving human health through artificial intelligence
• Strategic decisions of Life Sciences companies in the face of the Covid-19 challenge
• Lean, key of the operational success
• The Social Return on Investment in biomedical companies, a rising value?
• The Promised Land
• Digital Health: Revolutionising the Sector
• Convergence between Biopharmaceutical and Medtech sectors
• SME Instrument, keys to the succes of your project
• Innovation in Tech Transfer
• Internationalisation Strategies
• Market Access and Reimbursement
• Communication strategies to grow your business
• Rating companies. Beyond the numbers
• Medical devices: tips & tricks for managing the process of prototyping and validation
• Organisational models for biocompanies and change management
• Big data in healthcare: bioinformatics' upcoming challenges for today's companies
• Biotaxes: incentives for science
• Licences, the art of buying and selling intangibles in biotechnology
• Protecting, transferring, using patents and knowledge. Which strategy suits me best?
• Flexible planning in clinical development
• Improving your drug discovery strategy
• Investment models in biotechnology companies
• The keys to success in accessing international funding

Photo gallery